Insomnia Patients Report Better Sleep After Starting Medical Cannabis in Two-Year Study

Patients prescribed medical cannabis for insomnia reported better sleep quality at every follow-up in a two-year study from the UK Medical Cannabis Registry. The analysis included 211 patients. Their average self-rated sleep quality rose from 2.46 out of 10 before their first prescription to an estimated 5.14 at 24 months. The study had no comparison group, so researchers could not determine how much of the change was due to cannabis.
Suncoast NORML credits National NORML for its November 19, 2026 coverage of the study. Read National NORML’s original article on medical cannabis and sleep quality.
What did the medical cannabis and insomnia study find?
Researchers asked patients to rate their sleep before their first prescription and at 1, 3, 6, 12, 18, and 24 months. The registry included patients prescribed various cannabis-based medicines, including oils and dried flower. Of the 211 people in the analysis, 126 were already using cannabis when they entered the study. Patients who started with the lowest sleep ratings were more likely to see a clinically meaningful improvement by the two-year mark.
Seventeen participants, about 8%, reported adverse events. The study recorded events of varying severity, including fatigue, dry mouth, dizziness, and worsening insomnia. The authors reported no life-threatening or disabling events.
What can a two-year registry study tell us about sleep?
Two years of follow-up gives researchers a longer view of how patients rated their sleep after starting a prescription. The study relied on patient questionnaires, and the team used statistical estimates to account for missing responses. Without a control group or objective measurements of sleep, changes such as whether patients slept longer or woke less often remain uncertain. Patient expectations and differences in who enrolled or kept responding could also have influenced the results.
Why this matters to Florida patients
For Suncoast NORML, the study raises a practical research question. If patients report better sleep over months or years, which formulations account for that improvement, for whom, and with what side effects? Longer randomized trials could compare specific formulations and pair patient reports with objective sleep measures. That would give patients and clinicians a better basis for weighing benefits and risks.
Frequently asked questions
Does medical cannabis help with insomnia?
Patients in this UK registry reported better sleep after receiving cannabis prescriptions for insomnia. Whether cannabis itself caused the improvement remains an open question because the study lacked a comparison group.
How long did patients report better sleep?
Average self-rated sleep quality was higher than baseline at every scheduled follow-up, from one month through two years. The two-year result reflects the study’s group estimate and accounts for missing survey responses.
Did the study identify the best cannabis product for sleep?
The researchers observed differences among patients prescribed different products. Because the study did not randomly assign products, it leaves open which formulation or dose works best for insomnia.


.png)




Comments